BPA Call 36C24625A0001-36C24625N0173

Award Date 10/3/24
Potential Completion Date 9/30/25
Potential Value $176K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) to Diagnostica Stago Inc., a manufacturer of coagulation testing equipment, reagents, and supplies. The $12,686.55 BPA is part of the VA's Veterans Integrated Service Network (VISN) program and will provide the VA with Diagnostica Stago's STA line of compact and automated hemostasis analyzers, specialty coagulation reagents and controls, and preventative maintenance or cost-per-test services. The...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded to Diagnostica Stago Inc. by the Veterans Integrated Service Network (VISN) 6 of the U.S. Department of Veterans Affairs (VA). The contract, valued at $118,136.66, is for the provision of coagulation testing equipment, reagents, and supplies to support clinical laboratory operations at VA medical facilities. Diagnostica Stago, a manufacturer of hemostasis and thrombosis testing products, is providing its STA line of compact...
This is a Blanket Purchase Agreement (BPA) contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17 (VISN 17) to Diagnostica Stago Inc., a manufacturer of medical devices and consumables for hemostasis and thrombosis testing. The contract, with a ceiling value of $362,085.80, is for the provision of coagulation testing instrumentation, reagents, and supplies to support clinical laboratory operations at VA and Department of Defense (DOD) medical...
This is a Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 12 to Diagnostica Stago Inc., a manufacturer of medical devices and consumables for hemostasis and thrombosis testing. The BPA, valued at $81,890.70, is for the provision of coagulation tests on a cost-per-reportable-result basis over an 1-year ordering period. The contract supports the VA's clinical laboratory operations, providing specialized coagulation...
This is a Blanket Purchase Agreement (BPA) call awarded by the Veterans Integrated Service Network (VISN) 16 of the U.S. Department of Veterans Affairs (VA) to Diagnostica Stago Inc., a manufacturer of coagulation testing equipment and supplies. The contract, valued at $145,940.42, is for the provision of coagulation testing instrumentation and reagents to support clinical laboratory operations at VA medical facilities within VISN 16. Diagnostica Stago holds several Indefinite Delivery...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Diagnostica Stago Inc., a foreign-owned for-profit manufacturer of medical devices and consumables for hemostasis and thrombosis testing. The contract, which is part of the VA's Veterans Integrated Service Network (VISN) 20 program, is for the procurement of coagulation reagents and supplies to support clinical laboratory operations at VA and Department of Defense (DOD)...
This is a firm fixed price Blanket Purchase Agreement (BPA) Call awarded by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network (VISN) 16 to Diagnostica Stago Inc., a medical device manufacturer, for coagulation testing instrumentation, reagents, and supplies. The BPA has a ceiling value of $1,993.42 and a period of performance through September 30, 2024. This award is part of a larger VISN-wide BPA for coagulation testing, which enables VA medical facilities to...
This is a Blanket Purchase Agreement (BPA) contract awarded by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network (VISN) 16 to Diagnostica Stago Inc., a foreign-owned, for-profit manufacturer of medical devices and consumables specializing in hemostasis and thrombosis testing technologies. The contract, valued at $1,650.22, is for the provision of coagulation testing instrumentation, reagents, and supplies across the VISN-wide network. The contract is structured as a...
This is a firm fixed price Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 16 to Diagnostica Stago Inc., a foreign-owned for-profit manufacturer of medical devices and consumables. The BPA, valued up to $45,330.94, is for the provision of coagulation testing instrumentation, reagents, and supplies to support clinical laboratory operations at VA and Department of Defense (DOD) medical facilities across multiple VISN...
This is a Blanket Purchase Agreement (BPA) awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 20 to Diagnostica Stago Inc., a manufacturer of medical devices and supplies for hemostasis and thrombosis testing. The contract has a ceiling value of $73,500.00 and a period of performance through February 28, 2025. The BPA is for the procurement of coagulation reagents and supplies, including the company's STA line of compact and automated hemostasis...

This is a firm-fixed price Blanket Purchase Agreement (BPA) call issued by the Veterans Integrated Service Network (VISN) 6 of the U.S. Department of Veterans Affairs (VA) to Diagnostica Stago Inc., a manufacturer of coagulation testing equipment and supplies. The contract, valued at $176,070.86, provides the VA with a variety of coagulation analyzers, reagents, controls, and related products from Diagnostica Stago's GSA Schedule 66-III for Critical Analyzers, Laboratory Equipment and Supplies. This BPA call will support clinical laboratory operations at VA medical facilities located within VISN 6, enabling prothrombin time, partial thromboplastin time, fibrinogen, and D-dimer testing to aid in the evaluation of bleeding disorders, clotting factor deficiencies, anticoagulation therapy management, and thrombosis risk for patients. The contract has a performance period through September 30, 2025 and does not have a set-aside designation.

Generated 11/26/24, 9:37 AM